Predictive Oncology Correlations
POAI Stock | USD 1.11 0.01 0.91% |
The current 90-days correlation between Predictive Oncology and GlucoTrack is -0.35 (i.e., Very good diversification). The correlation of Predictive Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Predictive Oncology Correlation With Market
Significant diversification
The correlation between Predictive Oncology and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and DJI in the same portfolio, assuming nothing else is changed.
Predictive |
Moving together with Predictive Stock
0.84 | RVP | Retractable Technologies Earnings Call This Week | PairCorr |
0.72 | MLSS | Milestone Scientific Earnings Call This Week | PairCorr |
0.82 | PLX | Protalix Biotherapeutics | PairCorr |
Moving against Predictive Stock
0.45 | VINC | Vincerx Pharma Earnings Call This Week | PairCorr |
0.56 | ADVM | Adverum Biotechnologies | PairCorr |
0.48 | ATNF | 180 Life Sciences | PairCorr |
0.42 | INBX | Inhibrx Symbol Change | PairCorr |
0.4 | ZURA | Zura Bio Limited | PairCorr |
0.39 | MLTX | MoonLake Immunotherapeuti | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Predictive Stock performing well and Predictive Oncology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Predictive Oncology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
GCTK | 9.21 | (3.16) | 0.00 | (4.65) | 0.00 | 19.55 | 77.82 | |||
GMVD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
STSS | 9.02 | (2.12) | 0.00 | 0.79 | 0.00 | 19.35 | 76.46 | |||
MBOT | 7.23 | 1.65 | 0.19 | 0.92 | 7.27 | 16.23 | 121.64 | |||
NXGL | 3.51 | (0.61) | 0.00 | (0.36) | 0.00 | 5.64 | 23.35 | |||
PDEX | 3.75 | 0.17 | 0.04 | 0.16 | 4.22 | 8.67 | 34.56 | |||
LUCY | 4.07 | (0.69) | 0.00 | (0.70) | 0.00 | 7.18 | 28.66 | |||
ZJYL | 6.49 | 0.25 | 0.02 | 0.09 | 8.23 | 14.61 | 38.64 | |||
BNGO | 5.63 | (1.88) | 0.00 | 12.73 | 0.00 | 7.60 | 64.93 | |||
ISRG | 1.51 | (0.05) | 0.00 | (0.11) | 0.00 | 2.18 | 14.53 |
Predictive Oncology Corporate Management
Joshua MBA | Interim Officer | Profile | |
BS BSc | VP RD | Profile | |
Pamela MBA | Chief Officer | Profile | |
Raymond Vennare | CEO Chairman | Profile | |
DSc OD | VP Operations | Profile | |
Julia Kirshner | Chief Officer | Profile |